Wegovy 7.2 mg dose explained: who it's for, results and side effects

5 min read

wegovy-72
Ana Carolina Goncalves

Medically Reviewed By:

Ana Carolina Goncalves

GPhC Number 2088658

Rehma Gill

Written By:

Rehma Gill

GPhC Number 2225869

Updated: 16 November 2026

Share:

Wegovy 7.2 mg is a higher dose for some adults with obesity, and it isn't a starting dose. Here's who it's for, what the STEP UP trial found and how you'd move up to it.

Wegovy 7.2 mg is a higher-strength dose of Wegovy (semaglutide) for some adults with obesity. It's not a starting dose, and it's only used if your prescriber decides you need it after you've been on 2.4 mg.

This guide covers who it's for, what the STEP UP trial found, how you'd move up to it, the side effects and whether you can get it on the NHS.

Wegovy 7.2 mg is licensed in the UK, but it isn't right for everyone. A prescriber will assess your health, treatment history and other medicines first.


What is Wegovy 7.2 mg?

Wegovy copies a gut hormone called GLP-1. It lowers your appetite and how much you eat, and it's used alongside a reduced-calorie diet and more physical activity. Wegovy 7.2 mg works the same way as the lower doses, at a higher strength.1

It's a once-weekly injection for adults with obesity (a BMI of 30 or above). The 2.4 mg dose is also licensed for adults with a BMI of 27 to under 30 who have a weight-related condition, but 7.2 mg is for obesity only.1

Wegovy 7.2 mg compared with 2.4 mg Wegovy 2.4 mg is the usual maintenance dose for adults with obesity, or overweight with a weight-related condition, and is given as one 2.4 mg injection a week. Wegovy 7.2 mg is only for adults with obesity, only after at least 4 weeks on 2.4 mg and only if needed, and is given as three 2.4 mg injections, one after another, on the same day each week. Wegovy 2.4 mg and 7.2 mg 2.4 mg 7.2 mg Who it's for Adults with obesity, or overweight plus a condition Adults with obesity only When it's used Usual maintenance dose If needed, after 4+ weeks on 2.4 mg Injections each week One 2.4 mg injection Three 2.4 mg injections, one after another How often Once a week Once a week A prescriber decides if you need it Source: Wegovy FlexTouch and Wegovy 7.2 mg Summaries of Product Characteristics (Novo Nordisk, emc, 2026).

Both doses are taken once a week. At Pharmica, a 7.2 mg dose is given as three 2.4 mg injections, one after another, on your usual injection day. The SmPC allows either three 2.4 mg injections or a single 7.2 mg injection, depending on the device. Always follow your prescriber's instructions and the leaflet for the pen you're given.1


How effective is Wegovy 7.2 mg?

In the STEP UP trial, adults with obesity and no diabetes took Wegovy for 72 weeks, alongside a reduced-calorie diet and more physical activity. Across everyone in the trial, including people who stopped treatment, the average weight loss was 18.7% on 7.2 mg, 15.6% on 2.4 mg and 3.9% on placebo.1

Average weight loss in the STEP UP trial In the STEP UP trial, adults with obesity lost an average of 18.7% of their body weight after 72 weeks on Wegovy 7.2 mg and 15.6% on Wegovy 2.4 mg, compared with 3.9% on placebo. These averages include everyone who was randomised, including people who stopped treatment. Average weight loss after 72 weeks Wegovy 7.2 mg 18.7% Wegovy 2.4 mg 15.6% Placebo 3.9% Source: Wegovy 7.2 mg Summary of Product Characteristics (Novo Nordisk, emc, 2026), STEP UP. Includes people who stopped treatment.

If everyone had stayed on their assigned treatment, the averages would have been 20.7%, 17.5% and 2.4%.1

Results vary a lot from person to person. At 72 weeks:

  • 31.2% of people on 7.2 mg had lost at least 25% of their body weight, compared with 15.3% on 2.4 mg and none on placebo1
  • 33.2% and 16.7% was the equivalent if everyone had stayed on treatment1

These are group results, not a target for any one person. STEP UP measured weight loss at 72 weeks, which can't tell us how much further you might lose after that. Your prescriber will review your progress, how you're tolerating treatment and how long to continue.

Trials of different medicines used different people and different ways of counting results. Our guide to Wegovy vs Mounjaro explains how they compare.

A bigger average in a trial doesn't mean a bigger result for you. Diet, activity, dose and how you tolerate treatment all play a part.


How do you move up to Wegovy 7.2 mg?

You can't start on 7.2 mg. Wegovy goes up in steps, and 7.2 mg only comes after the 2.4 mg dose. If needed, a prescriber can increase your dose to 7.2 mg once a week after you've been on 2.4 mg for at least 4 weeks.1

If you have significant digestive symptoms, your prescriber may delay the increase or take you back to the previous dose until they improve.1

GPhC Number 2088658

Wegovy 7.2 mg isn't a dose to ask for on its own. It only comes after you've been on 2.4 mg for at least 4 weeks, and only if your prescriber thinks you need it. If your side effects are hard to manage, tell them, as they can delay the step up or take you back a dose.

Ana Carolina GoncalvesAna Carolina GoncalvesSuperintendent Pharmacist

If you haven't lost at least 5% of your starting weight after 6 months, your prescriber will decide with you whether to carry on.1

Do not move to a higher dose, or take more injections than you're prescribed, without your prescriber's approval.

Our Wegovy dosage guide has the full schedule, and how to take Wegovy walks you through the pen.


What are the side effects of Wegovy 7.2 mg?

The side effects are similar to other Wegovy doses, but some were more frequent on 7.2 mg in STEP UP. Side effects are most likely when you go up a dose.

In STEP UP, people on 7.2 mg reported:

  • Nausea: 38.9%, compared with 12.6% on placebo1
  • Diarrhoea: 24.2%, compared with 11.6% on placebo1
  • Vomiting: 22.1%, compared with 5.7% on placebo1
  • Constipation: 20.4%, compared with 7.6% on placebo1
  • Hair loss: 5.3%, compared with 1.0% on placebo1

Unusual skin sensations, called dysaesthesia, were also more common on 7.2 mg. They were reported by 21.6% of people, compared with 0.3% on placebo.1 Tell your prescriber if you notice them.

Our Wegovy side effects guide goes through the full list and what helps.

Severe stomach pain that does not go away, which may spread to your back, needs urgent medical attention. Stop Wegovy and call NHS 111 or go to A&E. Do not restart it if pancreatitis is confirmed. Sudden loss of vision also needs an urgent eye check.

Do not use Wegovy during pregnancy. Stop it at least 2 months before a planned pregnancy.1 Tell Pharmica about any personal or family history of thyroid cancer or MEN2, so the clinical team can check the service is suitable for you.


Can you get Wegovy 7.2 mg on the NHS?

In England, the NHS offers Wegovy for weight management at doses up to 2.4 mg, through specialist weight management services in line with NICE guidance (TA875).2 NICE is appraising the 7.2 mg dose, but as of November 2026 it hasn't published guidance on it, so the 7.2 mg dose isn't covered by TA875.3

Access and criteria can differ in Scotland, Wales and Northern Ireland, so check with your local NHS service.


Is Wegovy 7.2 mg right for you?

Wegovy 7.2 mg is licensed in the UK, and Pharmica lists it. Being licensed doesn't mean it's automatic, and it's not something you can order on its own.

To find out if it suits you, complete our online consultation. Pharmica will assess your age, treatment history, medical conditions and other medicines before deciding whether it can supply. If you're moving up from 2.4 mg, you may need to show evidence of your previous prescription.

Speak to your prescriber if you're finding side effects hard to manage or you aren't seeing the progress you hoped for. They can review your dose before you consider a change.

Popular Treatments

Wegovy® Injectable Pen

Wegovy® Injectable Pen

from £119.99

View Treatment ›
Mounjaro® Injectable Pen

Mounjaro® Injectable Pen

from £159.99

View Treatment ›
Wegovy® Oral Pill (Semaglutide Tablet)

Wegovy® Oral Pill (Semaglutide Tablet)

from £109.99

View Treatment ›


Frequently asked questions

Is Wegovy 7.2 mg approved in the UK?

Yes. Wegovy 7.2 mg is licensed in the UK as a once-weekly dose for adults with obesity, if needed after at least 4 weeks on 2.4 mg. Being licensed doesn't mean everyone can have it. A prescriber will assess your health, your treatment history and your other medicines before deciding whether it's suitable.

How much weight can you lose on Wegovy 7.2 mg?

In the STEP UP trial, adults on 7.2 mg lost an average of 18.7% of their body weight over 72 weeks, including people who stopped treatment. That's an average, not a target. Your own result depends on your diet, activity, how you tolerate treatment and how long you stay on it.

Can you start on Wegovy 7.2 mg?

No. Wegovy 7.2 mg isn't a starting dose. Wegovy goes up in steps, and a prescriber can only increase you to 7.2 mg after at least 4 weeks on 2.4 mg, and only if you need it. Do not change your dose, or take more injections than you're prescribed, without your prescriber's approval.

What is the difference between Wegovy 7.2 mg and 2.4 mg?

7.2 mg is three times the strength of 2.4 mg. It's only for adults with obesity, while 2.4 mg is also licensed for some adults with overweight. In STEP UP, average weight loss was 18.7% on 7.2 mg and 15.6% on 2.4 mg. At Pharmica, a 7.2 mg dose is given as three 2.4 mg injections, one after another, each week.

Is Wegovy 7.2 mg available on the NHS?

Not at the moment. NHS weight management services in England offer Wegovy at doses up to 2.4 mg, in line with NICE guidance (TA875), which doesn't cover 7.2 mg. NICE is appraising 7.2 mg but hasn't published guidance yet. Access can differ in Scotland, Wales and Northern Ireland, so check with your local NHS service.


Found this useful?

Sign up to get the latest Health Hub articles sent directly to your inbox, plus 5% off your first order.

References

  1. Novo Nordisk Limited. Wegovy 7.2 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium; 2026. medicines.org.uk/emc
  2. National Institute for Health and Care Excellence. Semaglutide for managing overweight and obesity (TA875). NICE; 2023. nice.org.uk
  3. National Institute for Health and Care Excellence. Semaglutide 7.2 mg for managing obesity [ID6699]: in development. NICE; 2026. nice.org.uk

This article is intended for informational purposes only and does not replace professional medical advice. Always read the patient information leaflet supplied with your medication and speak to a healthcare professional if you have specific concerns.

GPhC Number 2225869

Rehma Gill
Authored by:Rehma GillPharmacy
Manager

GPhC Number 2088658

Ana Carolina Goncalves
Reviewed by:Ana Carolina GoncalvesSuperintendent
Pharmacist

Find out more about our team of medical content authors and how we ensure the accuracy of our content with our content guidelines.

Popular Treatments

Wegovy® Injectable Pen

Wegovy® Injectable Pen

from £119.99

View Treatment ›
Mounjaro® Injectable Pen

Mounjaro® Injectable Pen

from £159.99

View Treatment ›
Wegovy® Oral Pill (Semaglutide Tablet)

Wegovy® Oral Pill (Semaglutide Tablet)

from £109.99

View Treatment ›
Weight Loss

Weight Loss Injections & Tablets

Lose weight with Pharmica - The UK’s #1 ranked weight loss service on Trustpilot

Start Consultation  
Confidential and secure
Quick and easy checkout
2.25 million+ customers
Confidential and secure
Quick and easy checkout
2.25 million+ customers

Weight Loss Injections & Tablets

Lose weight with Pharmica - The UK’s #1 ranked weight loss service on Trustpilot

Start Consultation  
Weight Loss

More than 255711 reviews

Star Star Star Star Star

Order was delivered promptly, useful as I'm not able to go out to shop.

Doreen, Jersey

Google Logo
Star Star Star Star Star

Each order is delivered quickly in safe and plain packaging.

Philip, Edinburgh

Trustpilot Logo
Star Star Star Star Star

First-class service. Great choice highly recommended.

Christopher, Norwich

Google Logo
Star Star Star Star Star

I spoke to the team via text message who were so helpful

Rebecca, London

Feefo Logo
Star Star Star Star Star

Good customer service on live chat. Wish more companies were like this.

Kevin, Plymouth

Trustpilot Logo
Star Star Star Star Star

Genuine medication at competitive prices. What more could you want!

Adrian, Brighton

Feefo Logo
Rehma

Need Help?

Get in touch with our friendly team

Call us on 0207 112 9014
Request a call back